Enoch Wong

Dr. Enoch Wong

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2020 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
DLDavid Liu
David Liu
SSSean Stevens
Sean Stevens
EWEnoch Wong
Enoch Wong
JFJonathan Fong
Jonathan Fong
KMKrinal Mori
Krinal Mori
TCthe VERITAS Collaborative
the VERITAS Collaborative

22 April 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
JLJerocin Vishani Loyala
Jerocin Vishani Loyala
BDBilly Down
Billy Down
EWEnoch Wong
Enoch Wong
BTBenjamin Tan
Benjamin Tan
(1) Background: Gastric cancer is a significant cause of cancer-related mortality worldwide. Weight loss and malnutrition associated with cancer are linked with increased mortality rates and reduced quality of life. Cancer cachexia, characterised by the loss of skeletal muscle, is associated with approximately 20% of cancer-related deaths and differs from malnutrition in that it cannot be fully reversed by nutritional support alone. It is now recognised that the primary pathophysiological process underlying cancer cachexia is chronic inflammation leading to increased calorie consumption. Current treatments that focus on nutritional supplementation, psychological counselling, appetite stimulation and reducing inflammation are lacking in efficacy. This review focuses on the evidence supporting the potential roles of natural anti-inflammatory products and their derivatives including fatty acids, probiotics, amino acids, curcumin, fucoidan, epigallocatechin-3-gallate, ginger, resveratrol and Boswellia serrata in the management of gastric cancer cachexia. (2) Results: While natural anti-inflammatory products show promise in a number of in vitro and in vivo studies, there are only a small number of human studies available. Where present, the evidence base is heterogeneous, with varying study methodologies and outcomes. (3) Conclusions: Natural anti-inflammatory products represent a potential adjunctive therapy for gastric cancer cachexia. Further research, particularly well-designed clinical trials, is needed to elucidate their optimal role, dosing and safety profiles in the management of gastric cancer cachexia.

30 October 2020 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
DLDavid Liu
David Liu
SSSean Stevens
Sean Stevens
EWEnoch Wong
Enoch Wong
JFJonathan Fong
Jonathan Fong
KMKrinal Mori
Krinal Mori
VCVERITAS collaborative
VERITAS collaborative

10 December 2020 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
JHJason Hong
Jason Hong
CSChristopher Steen
Christopher Steen
EWEnoch Wong
Enoch Wong
BKBen Keong
Ben Keong
We present a case of recurrent cholangitis caused by Shewanella algae, a lethal, emerging pathogen that clinicians should be made aware of. An 86-year-old man with a history of gastrectomy for peptic ulcer disease and a cerebrovascular accident with known choledocholithiasis presented with recurrent episodes of cholangitis that failed conservative antibiotic treatment regimens. Shewanella has been described to have increasing resistance to piperacillin and tazobactam. Both S. algae and multidrug-resistant Escherichia coli were co-isolated in this patient, which required broader spectrum antibiotics for successful treatment and management. A high index of suspicion is required if the history is suggestive of marine or aquatic exposure, which could expose the patient to this lethal pathogen. Re-thinking and re-taking the history are important cornerstones in refining the diagnosis when faced with recurrent presentations of the same problem.

26 July 2021 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ARAndrew T. Roberts
Andrew T. Roberts
JJJoseph Jaya
Joseph Jaya
PHPhil Ha
Phil Ha
UTUdit Thakur
Udit Thakur
OAOscar Aldridge
Oscar Aldridge
DCDaniel Croagh
Daniel Croagh

18 January 2018 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
DLDee Zhen Lim
Dee Zhen Lim
EWEnoch Wong
Enoch Wong
SHSayed Hassen
Sayed Hassen
YAYahya Al-Habbal
Yahya Al-Habbal
Bile duct injury (BDI) is a well-recognised complication of laparoscopic cholecystectomy (LC). Following a BDI, bile usually leaks into the peritoneal space and causes biliary peritonitis. This manifests as non-specific abdominal pain and fever occurring several days after the surgery. It can be managed by laparoscopic washout with or without bile duct repair. We present a rare case of retroperitoneal bile leak post-LC. The mechanism of injury here was likely partial avulsion from excessive traction of the cystic duct during intraoperative cholangiogram. Diagnosing retroperitoneal bile leak can be difficult because it is extremely rare and the presenting symptoms can be similar to an intraperitoneal bile leak. A high index of clinical suspicion is required. In cases of suspected bile leak, any mismatch between the exploratory laparoscopic findings and imaging findings should alert surgeons to consider the rare possibility of a retroperitoneal bile leak.